Square Pharmaceuticals PLC.'s latest marketcap:
As of 07/05/2025, Square Pharmaceuticals PLC.'s market capitalization has reached $1.49 B. According to our data, Square Pharmaceuticals PLC. is the 7557th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 1.49 B |
| Revenue (ttm) | 615.68 M |
| Net Income (ttm) | 190.75 M |
| Shares Out | 886.45 M |
| EPS (ttm) | 0.22 |
| Forward PE | 7.67 |
| Ex-Dividend Date | 11/24/2024 |
| Earnings Date | 10/23/2025 |
Square Pharmaceuticals PLC.'s yearly market capitalization.
| Date | Market Cap(BDT) | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | 1.49 B | -4.64% | 7557 |
| 12/30/2024 | 192.98 B | 3.52% | 6609 |
| 12/28/2023 | 186.42 B | 0.24% | 6232 |
| 12/29/2022 | 185.98 B | -2.1% | 5734 |
| 12/30/2021 | 189.97 B | -2.37% | 5726 |
| 12/30/2020 | 194.58 B | 21.3% | 4921 |
| 12/30/2019 | 160.41 B | -20.02% | 4744 |
| 12/27/2018 | 200.57 B | -9.88% | 3560 |
| 12/28/2017 | 222.54 B | 30.24% | 3771 |
| 12/29/2016 | 170.87 B | 8.01% | 3759 |
Company Profile
About Square Pharmaceuticals PLC.
Square Pharmaceuticals PLC., along with its subsidiaries, is a leading manufacturer and marketer of pharmaceutical products, serving both Bangladesh and international markets.
Product Portfolio
- Pharmaceuticals: Includes a wide range of treatments such as:
- Analgesics, anti-ulcerants, antibiotics, antidiabetics, and antifungals
- Cardiovascular, CNS, and respiratory medications
- Vitamins, steroids, and non-steroidal anti-inflammatory drugs (NSAIDs)
- Oncology, hepatobiliary, and urological preparations
- Specialty Products:
- Generic pharmaceuticals, infusions, and mouthwash
- Herbal and nutraceutical products
- Reusable insulin pens (AnsuPen brand)
- Agricultural & Animal Health: Crop care chemicals, insecticides, and veterinary products
Global Reach
The company exports its products to 42 countries, reinforcing its presence in international markets.
Corporate Background
Founded in 1958 and headquartered in Dhaka, Bangladesh, Square Pharmaceuticals PLC. operates as a subsidiary of Square Group.
Frequently Asked Questions
-
What is Square Pharmaceuticals PLC.'s (DSE-SQURPHARMA) current market cap?As of 07/05/2025, Square Pharmaceuticals PLC. (including the parent company, if applicable) has an estimated market capitalization of $1.49 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Square Pharmaceuticals PLC. (DSE-SQURPHARMA) rank globally by market cap?Square Pharmaceuticals PLC. global market capitalization ranking is approximately 7557 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.